Epi Holdings
Epi Holdings, a prominent player in the biotechnology sector, is headquartered in Hong Kong and operates extensively across Asia and beyond. Founded in the early 2000s, the company has established itself as a leader in the development and manufacturing of innovative biopharmaceutical products, particularly in the fields of immunology and oncology. Epi Holdings is renowned for its cutting-edge therapies and diagnostic solutions, which are distinguished by their efficacy and safety profiles. The company’s commitment to research and development has led to significant advancements in personalised medicine, positioning it favourably within the competitive landscape of the biotech industry. With a strong market presence and a portfolio of unique products, Epi Holdings continues to achieve notable milestones, contributing to the advancement of healthcare solutions globally.
DitchCarbon Score
How does Epi Holdings's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Epi Holdings's score of 9 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Epi Holdings's reported carbon emissions
In 2023, Epi Holdings reported total carbon emissions of approximately 3,853,720 kg CO2e, with Scope 1 emissions at about 469,600 kg CO2e and Scope 2 emissions at approximately 3,384,120 kg CO2e. This marks a significant increase in emissions compared to previous years, with total emissions in 2022 recorded at about 1,778,460 kg CO2e. In 2021, Epi Holdings achieved a total of approximately 17,640 kg CO2e, with Scope 1 emissions at about 9,190 kg CO2e and Scope 2 emissions at approximately 8,450 kg CO2e. The company has shown a reduction in emissions from 2017 to 2021, where total emissions were about 70,050 kg CO2e (45,470 kg CO2e from Scope 1 and 24,580 kg CO2e from Scope 2). Despite these fluctuations, Epi Holdings has not publicly committed to specific reduction targets or initiatives, nor have they joined any climate pledges. The absence of defined reduction strategies suggests a need for enhanced climate action within the organisation. Overall, Epi Holdings' emissions data reflects a complex trajectory, highlighting both past reductions and recent increases, underscoring the importance of establishing robust climate commitments moving forward.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2017 | 2018 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 45,470 | 00,000 | 0,000 | 000,000 | 000,000 |
| Scope 2 | 24,580 | 00,000 | 0,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Epi Holdings is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
